Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gugliotta

Showing results (401-410 of 469) with videos related to

Pageof 47
Sort By:
BMC Cancer|August 4, 2016
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutantsSimona Soverini, Caterina De Benedittis, Fausto Castagnetti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2013
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Anna Bossi, Ivan Cortinovis, et al.
Circulation|November 21, 2001
Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillationC Pappone, G Oreto, S Rosanio, et al.
Blood|December 9, 2004
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyGuido Finazzi, Vanesa Caruso, Roberto Marchioli, et al.
Annals of Hematology|June 4, 2025
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapyMarianna Gentilini, Beatrice Casadei, Cinzia Pellegrini, et al.
Leukemia Research|April 25, 2016
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasmsLuigi Gugliotta, Alessandra Iurlo, Gabriele Gugliotta, et al.
Blood|October 3, 2007
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective surveyMarco Ruggeri, Francesco Rodeghiero, Alberto Tosetto, et al.
Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Oncotarget|March 17, 2016
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patientsSimona Soverini, Caterina De Benedittis, Katerina Machova Polakova, et al.
American Journal of Hematology|August 26, 2009
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registryLorella Melillo, Alessia Tieghi, Anna Candoni, et al.
Pageof 47

Showing results (401-410 of 469) with videos related to

Sort By:
Pageof 47
BMC Cancer|August 4, 2016
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutantsSimona Soverini, Caterina De Benedittis, Fausto Castagnetti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2013
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Anna Bossi, Ivan Cortinovis, et al.
Circulation|November 21, 2001
Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillationC Pappone, G Oreto, S Rosanio, et al.
Blood|December 9, 2004
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyGuido Finazzi, Vanesa Caruso, Roberto Marchioli, et al.
Annals of Hematology|June 4, 2025
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapyMarianna Gentilini, Beatrice Casadei, Cinzia Pellegrini, et al.
Leukemia Research|April 25, 2016
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasmsLuigi Gugliotta, Alessandra Iurlo, Gabriele Gugliotta, et al.
Blood|October 3, 2007
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective surveyMarco Ruggeri, Francesco Rodeghiero, Alberto Tosetto, et al.
Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Oncotarget|March 17, 2016
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patientsSimona Soverini, Caterina De Benedittis, Katerina Machova Polakova, et al.
American Journal of Hematology|August 26, 2009
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registryLorella Melillo, Alessia Tieghi, Anna Candoni, et al.
Pageof 47